Skip to main content

Advertisement

Table 1 Clinical characteristics of alloHSCT patients

From: Utilization of TREC and KREC quantification for the monitoring of early T- and B-cell neogenesis in adult patients after allogeneic hematopoietic stem cell transplantation

  n=15 %
Median age (range) 57 (28–68)  
<50 5 30
>50 10 70
Sex   
female 8 53
male 7 47
Diagnosis   
AML 13 87
ALL 2 13
Transplant   
MUD 10 70
MRD 5 30
Conditioning   
full intensity 8 53
47 reduced intensity 7 47
GvHD (acute = + Chronic)   
yes 16 89
no 2 11
  1. AML, acute myeloid leukemia; MUD, matched unrelated donor; MRD, matched related donor; GvHD, graft-versus-host disease.